CDK2 and cancer: That is, cancer cells exiting mitosis with low levels of CDK2 (quiescent cells) would strictly depend upon CDK4/6 function to re-enter the cell cycle, whereas cells exiting mitosis with high levels of CDK2 (proliferating cells) would bypass the requirement for CDK4/6 activity.131